Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer

摘要

Background & Aims: Pediatric liver cancer is a rare but serious disease whose incidence is rising, and for which the therapeutic options are limited. Development of more targeted, less toxic therapies is hindered by the lack of an experimental animal model that captures the heterogeneity and metastatic capability of these tumors.